- Time
- Topic
- Speaker
- Moderator
- 10:00 - 10:30
-
When Dreams Signal Disease: The Role of RBD in the Prodromal Synucleinopathy Continuum
- Speaker:
Jee-Young Lee
- Moderator:
Shey-Lin Wu
- Jee-Young Lee
- MD, PhD
-
Professor of neurology, Seoul National University College of Medicine
Director of Parkinson and Rare Disease Center, Seoul Metropolitan Government-Seoul National University Boramae Medical Center
E-mail:wieber77@gmail.com
Executive Summary:
Dr. Jee-Young Lee is a professor of neurology at Seoul National University (SNU) College of Medicine and a director of Parkinson and Rare disease Center of SNU-SMG Boramae Medical Center. She graduated from SNU College of Medicine and earned a PhD in neuroscience from the same institution. She received neurological residency training and a movement disorders fellowship at SNU Hospital. Her main academic interests include functional and molecular imaging and longitudinal multimodal biomarker cohort study in Parkinson’s disease and related neurodegenerative disorders. She was elected to join the leadership program (LEAP) of the International Movement Disorder Society (MDS)-AOS section in 2016 and is currently an active member of the executive committee of the MDS-AOS section, chair of the MDS-AOS Education committee, and a member of the steering committee of the MDS Neuroimaging Study Group. She also serves as Research Director of Korean MDS.
Lecture Abstract:
Synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, have a long prodromal phase before overt clinical signs emerge and a diagnosis can be established. During this prodromal phase, individuals may experience both specific and nonspecific symptoms associated with the underlying pathological processes in the central nervous system. It is now well established that REM sleep without atonia (RSWA) and dream-enactment behaviors can serve as early markers of underlying synucleinopathy. This talk will discuss clinically and neuroimaging-supported assessments of individuals with RBD along the prodromal synucleinopathy continuum, as well as various prognostic and staging biomarkers that may help characterize the progression of neurodegeneration.
- Time
- Topic
- Speaker
- Moderator
- Sung-Pin Fan
- MD, MMedSc
-
Visiting Staff, Neurology Department, National Taiwan University Hospital
E-mail:sungpinfan@ntu.edu.tw
Executive Summary:
Dr. Sung-Pin Fan is currently an attending physician in the Department of Neurology at National Taiwan University Hospital (NTUH). He completed his comprehensive neurology residency and fellowship training at NTUH. Dr. Fan earned his Master’s degree from the Institute of Clinical Medicine at National Taiwan University (NTU) and is currently pursuing a Doctoral degree in the Program for Precision Health and Intelligent Medicine at NTU. His research interests focus on Parkinson’s disease, Wilson’s disease, and the development of neuroimaging biomarkers, as well as the integration of machine learning in clinical neurology. Dr. Fan has authored multiple peer-reviewed articles specializing in neuroimaging and digital biomarkers.
- Time
- Topic
- Speaker
- Moderator
- Tsung-Lin Lee
- MD
-
Attending Physician, Department of Neurology, National Cheng Kung University Hospital, Tainan, Taiwan
Editor-in-Chief, Taiwan Neurological Society Newsletter
Committee Member, Continuing Medical Education Committee, International Parkinson and Movement Disorder Society
E-mail:c2481023@hotmail.com
Executive Summary:
Dr. Tsung-Lin Lee is an attending physician in the Department of Neurology at National Cheng Kung University Hospital, Tainan, Taiwan, and a PhD candidate in Biomedical Engineering at National Cheng Kung University. His clinical and academic work focuses on Parkinson’s disease and movement disorders, with particular interests in deep brain stimulation, neuromodulation, clinical neurophysiology, and translational gait analysis.
Dr. Lee has been actively involved in both national and international professional service. He serves as Editor-in-Chief of the Taiwan Neurological Society Newsletter and is a Committee Member of the Continuing Medical Education Committee of the International Parkinson and Movement Disorder Society.
His recent academic work reflects a strong commitment to movement disorders, neurodegeneration, and translational clinical research. Dr. Lee is dedicated to advancing neurological care, research, and professional education, with a particular emphasis on integrating clinical practice with emerging neurotechnology.
Lecture Abstract: